1. Home
  2. Analysis
  3. Pred-forte
  4. Daliresp

Pred forte and Daliresp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pred forte (prednisolone acetate) and Daliresp (roflumilast). Common drug interactions include infusion site bruising among females.

The phase IV clinical study analyzes what interactions people have when they take Pred forte and Daliresp. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Pred forte?

Pred forte has active ingredients of prednisolone acetate. It is often used in uveitis. eHealthMe is studying from 3,229 Pred forte users. Check the latest studies of Pred forte.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.

On Aug, 01, 2026

12 people who take Pred forte and Daliresp together, and have interactions are studied.

Pred forte and Daliresp drug interactions.

What are the common drug interactions of Pred Forte and Daliresp, by gender? *:

female:

  1. Infusion site bruising
  2. Infusion site swelling
  3. Abscess (pus)
  4. Infusion site erythema (reddening of the skin at infusion site)
  5. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  6. Infusion site haemorrhage (bleeding from infusion site)
  7. Infusion site pain
  8. Pain
  9. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  10. Surgery

male:

n/a

What are the common drug interactions of Pred Forte and Daliresp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chills (felling of cold)
  2. Discomfort
  3. Infusion site swelling
  4. Nausea (feeling of having an urge to vomit)
  5. Oral candidiasis (fungal infection of mouth)
  6. Pain
  7. Pneumonia
  8. Sinusitis (inflammation of sinus)
  9. Vomiting
  10. Wheezing (a high-pitched whistling sound made while you breath)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 12 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pred forte and Daliresp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pred forte and Daliresp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pred forte:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Daliresp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pred forte and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daliresp and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on prednisolone acetate and roflumilast (the active ingredients of Pred forte and Daliresp, respectively), and Pred forte and Daliresp (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.